Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure.

von Haehling S, Filippatos GS, Papassotiriou J, Cicoira M, Jankowska EA, Doehner W, Rozentryt P, Vassanelli C, Struck J, Banasiak W, Ponikowski P, Kremastinos D, Bergmann A, Morgenthaler NG, Anker SD.

Eur J Heart Fail. 2010 May;12(5):484-91. doi: 10.1093/eurjhf/hfq031. Epub 2010 Mar 9.

2.
3.

Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.

Khan SQ, O'Brien RJ, Struck J, Quinn P, Morgenthaler N, Squire I, Davies J, Bergmann A, Ng LL.

J Am Coll Cardiol. 2007 Apr 10;49(14):1525-32. Epub 2007 Mar 26.

4.

The effect of diabetes on the diagnostic and prognostic performance of mid-region pro-atrial natriuretic peptide and mid-region pro-adrenomedullin in patients with acute dyspnea.

Wu AH, Tabas J, Stein J, Potocki M, Mueller C, McCord J, Richards M, Hartmann O, Nowak R, Peacock WF, Ponikowski P, Moeckel M, Hogan C, Filippatos GS, Di Somma S, Anand I, Ng L, Neath SX, Christenson R, Morgenthaler NG, Anker SD, Maisel AS.

Biomarkers. 2012 Sep;17(6):490-7. doi: 10.3109/1354750X.2012.687014. Epub 2012 May 23.

PMID:
22616939
5.

Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.

Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng L, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, von Haehling S, Bergmann A, Morgenthaler NG, Anker SD.

J Am Coll Cardiol. 2010 May 11;55(19):2062-76. doi: 10.1016/j.jacc.2010.02.025.

6.

Mid-regional pro-adrenomedullin in acute heart failure: a better biomarker or just another biomarker?

Potocki M, Ziller R, Mueller C.

Curr Heart Fail Rep. 2012 Sep;9(3):244-51. doi: 10.1007/s11897-012-0096-6. Review.

PMID:
22733501
7.

Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.

Maisel A, Mueller C, Nowak RM, Peacock WF, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng LL, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Hartmann O, Morgenthaler NG, Anker SD.

J Am Coll Cardiol. 2011 Aug 30;58(10):1057-67. doi: 10.1016/j.jacc.2011.06.006.

8.

Comparison of long-term prognostic value of N-terminal-proBNP and midregional-pro-adrenomedullin in patients with acute myocardial infarction.

Walter T, Brueckmann M, Lang S, Sauer T, Fiedler E, Papassotiriou J, Behnes M, Elmas E, Borggrefe M, Bertsch T.

Clin Lab. 2010;56(7-8):303-9.

PMID:
20857894
9.

Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction.

Klip IT, Voors AA, Anker SD, Hillege HL, Struck J, Squire I, van Veldhuisen DJ, Dickstein K; OPTIMAAL investigators.

Heart. 2011 Jun;97(11):892-8. doi: 10.1136/hrt.2010.210948. Epub 2011 Mar 17.

PMID:
21415071
10.

Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population.

Brouwers FP, de Boer RA, van der Harst P, Struck J, de Jong PE, de Zeeuw D, Gans RO, Gansevoort RT, Hillege HL, van Gilst WH, Bakker SJ.

Heart. 2012 Sep;98(18):1348-53. doi: 10.1136/heartjnl-2012-302390. Epub 2012 Jul 21.

PMID:
22821276
11.

Mid-region pro-adrenomedullin adds predictive value to clinical predictors and Framingham risk score for long-term mortality in stable outpatients with heart failure.

Xue Y, Taub P, Iqbal N, Fard A, Clopton P, Maisel A.

Eur J Heart Fail. 2013 Dec;15(12):1343-9. doi: 10.1093/eurjhf/hft116. Epub 2013 Jul 25.

12.

Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study.

Dhillon OS, Khan SQ, Narayan HK, Ng KH, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL.

J Am Coll Cardiol. 2010 Jul 6;56(2):125-33. doi: 10.1016/j.jacc.2010.01.060.

13.

N-terminal brain natriuretic peptide, but not anemia, is a powerful predictor of mortality in advanced heart failure.

Gardner RS, Chong KS, Morton JJ, McDonagh TA.

J Card Fail. 2005 Jun;11(5 Suppl):S47-53.

PMID:
15948101
14.

The association of mid-regional pro-adrenomedullin and mid-regional pro-atrial natriuretic peptide with mortality in an incident dialysis cohort.

Gouya G, Sturm G, Lamina C, Zitt E, Freistätter O, Struck J, Wolzt M, Knoll F, Lins F, Lhotta K, Neyer U, Kronenberg F.

PLoS One. 2011 Mar 7;6(3):e17803. doi: 10.1371/journal.pone.0017803.

16.

A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non-ischaemic origin.

Stanton E, Hansen M, Wijeysundera HC, Kupchak P, Hall C, Rouleau JL; PRAISE-2 study investigators.

Eur J Heart Fail. 2005 Jun;7(4):557-65.

17.

Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study.

Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Müller B.

Crit Care. 2005;9(6):R816-24. Epub 2005 Nov 15.

18.

Associations of mid-regional pro-adrenomedullin levels to cardiovascular and metabolic abnormalities, and mortality in an elderly population from the community.

Eggers KM, Venge P, Lindahl B, Lind L.

Int J Cardiol. 2013 Oct 9;168(4):3537-42. doi: 10.1016/j.ijcard.2013.05.005. Epub 2013 May 27.

PMID:
23722054
19.

Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers.

George J, Patal S, Wexler D, Abashidze A, Shmilovich H, Barak T, Sheps D, Keren G.

Arch Intern Med. 2005 Jun 13;165(11):1304-9.

PMID:
15956012
20.

Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome.

Zhang F, Li X, Ochs T, Chen L, Liao Y, Tang C, Jin H, Du J.

J Am Coll Cardiol. 2012 Jul 24;60(4):315-20. doi: 10.1016/j.jacc.2012.04.025.

Supplemental Content

Support Center